The relationship between ex vivo anti-factor Xa levels and efficacy/safety of low molecular weight heparin.
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- January 1989
has subject area
- Endocrinology & Metabolism (Science Metrix)
- Factor Xa Inhibitors (MeSH)
- Hemorrhage (MeSH)
- Heparin, Low-Molecular-Weight (MeSH)
- Humans (MeSH)
- Postoperative Complications (MeSH)
- Thrombophlebitis (MeSH)